Ozempic face? Botox maker reports boost from 'sagging face' trend

Per CNBC, Botox maker Galderma is reporting a business boost tied to "Ozempic face"—the facial sagging and volume loss from rapid weight loss with GLP-1 medications. The company expects increased use of these weight-loss drugs to drive demand for aesthetic treatments addressing the facial changes.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton